News

FIGO supports World Prematurity Day 2017

Statement from the International Federation of Gynecology and Obstetrics (FIGO) to highlight World Prematurity Day 2017 (17 November 2017). Please click here to view the statement.

FIGO joins IDF in highlighting World Diabetes Day 2017

Statement from the International Federation of Gynecology and Obstetrics (FIGO) to highlight World Diabetes Day 2017 (14 November 2017). Please click here to view the statement.

Wellbeing of Women’s Project Grants' round for 2018 is now open!

Wellbeing of Women’s Project Grants' round for 2018 is now open! The deadline is 16 February 2018 . WOW (with whom FIGO has a Memorandum of Understanding) is inviting applications to its Research Project Grants. These awards are open to all researchers leading their own work in women...

MHRA warns against HIV home-testing kits

The Medicines and Healthcare products Regulatory Agency (MHRA) has warned that people should not use the HIV/Aids Home Test Kit as it could be giving users unreliable results. According to the BBC, the medicines regulator has seized 114 of the kits from two suppliers in the UK and advises anyone...

Pregnant British mums the ‘world’s worst’ for alcohol consumption

A recent study has found that pregnant British mums are one of the most likely in the world to consume alcohol, harming their unborn babies as a result. According to the Canadian Institute of Mental Health Policy and Research, children across the UK suffer four times more alcohol-related birth...

New recommendations for menopausal symptoms in breast cancer survivors

A new review published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism has made a number of recommendations for how women who have survived breast cancer can better manage the symptoms of the menopause. The recommendations include smoking cessation, maintaining a...

South Korea fertility rate falls

South Korea’s fertility rate dropped to a seven-year low in 2016, according to Statistics Korea. Last year, women in the country had an average 1.17 babies in their lifetimes, a 5.4 per cent fall from the previous year. The fall is thought to be because women are delaying marriage and having...

Cancer patients still facing lack of information about impact on fertility

Patients undergoing cancer treatment are still not getting enough support when it comes to the impact that the disease and its treatment has on their fertility, a new study has discovered. According to findings from the Kids Cancer Center at Sydney Children’s Hospital in Australia, reported...

Religious women likely to have less knowledge about HPV virus vaccinations

Young women who closely follow a religion are less likely to have access to important information about vaccines protecting them against the human papillomavirus (HPV), a new study has discovered. University of Utah's Huntsman Cancer Institute and College of Nursing in Salt Lake City, US,...

US improving women's access to female condoms

Women across the US are getting better access to female condoms as an effective form of contraception, it has been reported. According to a study from Columbia University School of Social Work in New York City, US, the number of states that are now making female condoms available to women through...

Study: India must avoid a breast cancer epidemic

A lack of early diagnosis of breast cancer in India is leading the country towards an epidemic, it has been reported. According to a study published in the Journal of Business Research - which was the first of its kind to look at breast cancer in India - educating men could be key to encouraging...

FGM revealed to be widespread in Kerala

Female genital mutilation (FGM) is still being carried out in several parts of Kerala in India, including Thiruvananthapuram, even though it is being labelled a criminal offence, it has been reported. According to Sahiyo - an organisation working to stop the practice - FGM is still being performed...

PrEP variation ‘safe and well-tolerated in women’

Pre-exposure prophylaxis (PrEP) regimens containing the antiretroviral drug maraviroc have been found to be safe and well-tolerated in women at risk of HIV infection. This is compared with mtricitabine-tenofovir disoproxil fumarate, sold by the brand name Truvada, according to results from a phase...